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Several small molecule antagonists of the HIV co-recep-
tors CCR5 and CXCR4 are being developed as HIV entry
inhibitors, but side effects have been observed in clinical
trials that are likely due to agonist activity and/or cross-
reactivity with closely related receptors. In order to
develop high resolution maps of the binding sites for
these antagonists that can be exploited to improve their
activity and specificity, we are synthesizing derivatives of
CCR5 and CXCR4 antagonists which contain photo-
crosslinking groups at a variety positions in the molecules
and that retain high affinity and activity against the recep-
tors. Derivatives of two CCR5 antagonists and one CXCR4
antagonist have been crosslinked to their receptors on
cells, and the interaction sites are being mapped by mass
spectrometry. Techniques for purification, crosslinking,
CNBr and/or trypsin digestion, and LC/MS/MS mass spec-
trometry of highly hydrophobic peptides initially devel-
oped using the rhodopsin GPCR system have been
applied with some success to CCR5 and CXCR4, although
these represent particular challenges due to the relative
paucity of Met residue cleavage sites compared to rho-
dopsin and resistance to tryptic digestion. Nevertheless,
peptides covering most of the extracellular and transmem-
brane regions of CCR5 that could interact with an antago-
nist can be identified, and affinity purification methods
are being developed to isolate CXCR4 peptides
crosslinked to derivatives of the antagonist T-140 that
should facilitate the identification and localization of the
crosslinking sites within the proteins.
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